Aktie A0M4NN GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Guizhou Yibai Pharmaceutical Co., Ltd.

Aktien

A0M4NN

CNE000001H03

600594

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 25.06.2024 		% 5 Tage % 1. Jan.
2,94 CNY +0,68 % Intraday Chart für Guizhou Yibai Pharmaceutical Co., Ltd. -5,77 % -48,33 %
18.04. Guizhou Yibai Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
2023 YiBai Pharma will bis zu 40 Millionen Yuan Aktien zurückkaufen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
YiBai Pharma to Repurchase Up to 40 Million Yuan Shares
Guizhou Yibai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
GuiZhou YiBai Pharma to Book 2022 Loss on Policy Changes, COVID-19
Guizhou Yibai Pharmaceutical Completes Construction of $84.5 Million Factory
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Guizhou Yibai Traditional Chinese Medicine Formula Granules Pharmaceutical Co., Ltd. announced that it expects to receive CNY 179.8539 million in funding from Guizhou Yibai Pharmaceutical Co., Ltd., Guizhou Province Agricultural and Rural Modernization Development Equity Investment Fund Partnership
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Guizhou Yibai Pharmaceutical Co., Ltd. completed the acquisition of 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership)
Guizhou Yibai Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire a 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership) for approximately CNY 340 million.
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4NN Aktie
  4. Nachrichten Guizhou Yibai Pharmaceutical Co., Ltd.
  5. Andere Sprachen